Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
Clinical trial NCT02470702 · COMPLETED
Trial details
- NCT number
- NCT02470702
- Sponsor
- Melinta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.